Allied Capital Corporation (ALD) -0.19

Trade ALD
NOW!
Last Trade:4.45Short Ratio:2.90
Last Trade Time:4:03pmDay Range:3.98 - 4.66
Ask:Year Range:1.00 - 4.69
Bid:One Year Target:3.88
Open:4.64Exchange:NYSE
Volume:2743943EBITDA:242.6M
Prev. Close:4.64Market Cap:800.7M
50 Day Moving:4.2653Div Yield:
200 day moving:3.6644PE:

Related RealMoney articles from TheStreet.com

CIT Surges; Privatization Unlikely

Four Leading Independent Proxy Advisory Firms Recommend Vote “For” Proposed Merger of Ares Capital and Allied Capital; Allied Capital Urges all Shareholders to Vote Their Shares

Posted on 03/17/10 at 2:48pm
WASHINGTON--(BUSINESS WIRE)-- Allied Capital Corporation (NYSE: ALD) announced today that four leading independent proxy advisory firms, RiskMetrics Group (formerly Institutional Shareholder Services, or ISS), Glass Lewis & Company, Egan-Jones Proxy Services, and Proxy Governance, Inc.
Click here to read the rest of the article

Allied Capital: The Trend Continues Higher (ALD)

Posted on 03/15/10 at 2:24pm
SmarTrend identified an Uptrend for Allied Capital (NYSE: ALD) on September 17, 2009 at $3.49. In approximately 6 months, Allied Capital has returned 31.2% as of today's recent price of $4.58.
Click here to read the rest of the article

Genetix Pharmaceuticals Secures $35M in Series B Funding

Posted on 03/12/10 at 9:09am
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genetix Pharmaceuticals, a leading gene therapy company developing breakthrough treatments for severe genetic disorders, announced today that it has completed a $35 million Series B financing with new investors Third Rock Ventures and Genzyme Ventures joining TVM Capital, Forbion and Easton Ca
Click here to read the rest of the article

Genetix Pharmaceuticals Appoints Mitchell Finer, Ph.D. as Chief Scientific Officer

Posted on 03/12/10 at 9:09am
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genetix Pharmaceuticals, a leading gene therapy company developing breakthrough treatments for severe genetic disorders, announced today the appointment of Mitchell Finer, Ph.D. as Chief Scientific Officer. Dr.
Click here to read the rest of the article

Market Roundup (MSFT, GOOG, PSEC, ALD, ARCC, AAPL, AIG, TRH, RCNI)

Posted on 03/05/10 at 3:08pm
Microsoft (NASDAQ: MSFT) said it will continue its strategy to expand its share in China’s Internet search market, regardless of the outcome of the spat between Google (NASDAQ: GOOG) and China. MSFT wants to aggressively promote its search and cloud computing services in the country.
Click here to read the rest of the article
Posted in

Allied Capital: The Trend Continues Up (ALD)

Posted on 03/05/10 at 12:00pm
SmarTrend identified an Uptrend for Allied Capital (NYSE: ALD) on September 17, 2009 at $3.49. In approximately 6 months, Allied Capital has returned 31.2% as of today's recent price of $4.58.
Click here to read the rest of the article

Ares Capital and Allied Capital Announce Allied Capital’s Intention to Declare a Special Dividend to Allied Capital Shareholders upon Obtaining Shareholder Approval of the Merger Transaction

Posted on 03/03/10 at 11:30am
NEW YORK & WASHINGTON--(BUSINESS WIRE)-- Ares Capital Corporation (Nasdaq: ARCC) and Allied Capital Corporation (NYSE: ALD) announced today Allied Capital’s intention to declare a special dividend of $0.20 per share to Allied Capital shareholders in
Click here to read the rest of the article

Ares Capital and Allied Capital Announce Allied Capital’s Intention to Declare a Special Dividend to Allied Capital Shareholders upon Obtaining Shareholder Approval of the Merger Transaction

Posted on 03/03/10 at 11:18am
NEW YORK & WASHINGTON--(BUSINESS WIRE)-- Ares Capital Corporation (Nasdaq: ARCC) and Allied Capital Corporation (NYSE: ALD) announced today Allied Capital’s intention to declare a special dividend of $0.20 per share to Allied Capital shareholders in
Click here to read the rest of the article

SmarTrend Detects Continued Buying Pressure in Shares of Allied Capital (ALD)

Posted on 02/26/10 at 12:01pm
SmarTrend identified an Uptrend for Allied Capital (NYSE: ALD) on September 17, 2009 at $3.49. In approximately 5 months, Allied Capital has returned 20.1% as of today's recent price of $4.19.
Click here to read the rest of the article

Allied Capital Announces 2009 Financial Results

Posted on 02/24/10 at 4:11pm
WASHINGTON--(BUSINESS WIRE)-- Allied Capital Corporation (NYSE: ALD) today announced 2009 financial results. Highlights for 2009
Click here to read the rest of the article